China · Delayed Price · Currency is CNY Tibet Weixinkang Medicine Statistics
Total Valuation
SHA:603676 has a market cap or net worth of CNY 4.58 billion. The enterprise value is 3.54 billion.
| Market Cap | 4.58B |
| Enterprise Value | 3.54B |
Important Dates
The last earnings date was Friday, April 24, 2026.
| Earnings Date | Apr 24, 2026 |
| Ex-Dividend Date | Nov 26, 2025 |
Share Statistics
SHA:603676 has 432.33 million shares outstanding. The number of shares has increased by 0.61% in one year.
| Current Share Class | 432.33M |
| Shares Outstanding | 432.33M |
| Shares Change (YoY) | +0.61% |
| Shares Change (QoQ) | -1.94% |
| Owned by Insiders (%) | 22.57% |
| Owned by Institutions (%) | 3.61% |
| Float | 95.77M |
Valuation Ratios
The trailing PE ratio is 21.15.
| PE Ratio | 21.15 |
| Forward PE | n/a |
| PS Ratio | 3.94 |
| PB Ratio | 2.97 |
| P/TBV Ratio | 3.01 |
| P/FCF Ratio | 33.34 |
| P/OCF Ratio | 20.55 |
| PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.88, with an EV/FCF ratio of 25.77.
| EV / Earnings | 16.35 |
| EV / Sales | 3.05 |
| EV / EBITDA | 11.88 |
| EV / EBIT | 14.20 |
| EV / FCF | 25.77 |
Financial Position
The company has a current ratio of 3.74, with a Debt / Equity ratio of 0.01.
| Current Ratio | 3.74 |
| Quick Ratio | 3.31 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | 0.04 |
| Debt / FCF | 0.09 |
| Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is 14.38% and return on invested capital (ROIC) is 39.73%.
| Return on Equity (ROE) | 14.38% |
| Return on Assets (ROA) | 8.10% |
| Return on Invested Capital (ROIC) | 39.73% |
| Return on Capital Employed (ROCE) | 15.73% |
| Weighted Average Cost of Capital (WACC) | 4.45% |
| Revenue Per Employee | 1.69M |
| Profits Per Employee | 314,445 |
| Employee Count | 689 |
| Asset Turnover | 0.60 |
| Inventory Turnover | 8.76 |
Taxes
In the past 12 months, SHA:603676 has paid 52.91 million in taxes.
| Income Tax | 52.91M |
| Effective Tax Rate | 19.63% |
Stock Price Statistics
The stock price has increased by +0.76% in the last 52 weeks. The beta is 0.04, so SHA:603676's price volatility has been lower than the market average.
| Beta (5Y) | 0.04 |
| 52-Week Price Change | +0.76% |
| 50-Day Moving Average | 10.70 |
| 200-Day Moving Average | 11.55 |
| Relative Strength Index (RSI) | 51.63 |
| Average Volume (20 Days) | 2,353,553 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, SHA:603676 had revenue of CNY 1.16 billion and earned 216.65 million in profits. Earnings per share was 0.50.
| Revenue | 1.16B |
| Gross Profit | 714.81M |
| Operating Income | 249.37M |
| Pretax Income | 269.57M |
| Net Income | 216.65M |
| EBITDA | 293.56M |
| EBIT | 249.37M |
| Earnings Per Share (EPS) | 0.50 |
Balance Sheet
The company has 1.05 billion in cash and 11.81 million in debt, with a net cash position of 1.04 billion or 2.41 per share.
| Cash & Cash Equivalents | 1.05B |
| Total Debt | 11.81M |
| Net Cash | 1.04B |
| Net Cash Per Share | 2.41 |
| Equity (Book Value) | 1.54B |
| Book Value Per Share | 3.62 |
| Working Capital | 1.00B |
Cash Flow
In the last 12 months, operating cash flow was 223.03 million and capital expenditures -85.59 million, giving a free cash flow of 137.44 million.
| Operating Cash Flow | 223.03M |
| Capital Expenditures | -85.59M |
| Depreciation & Amortization | 44.19M |
| Net Borrowing | n/a |
| Free Cash Flow | 137.44M |
| FCF Per Share | 0.32 |
Margins
Gross margin is 61.51%, with operating and profit margins of 21.46% and 18.64%.
| Gross Margin | 61.51% |
| Operating Margin | 21.46% |
| Pretax Margin | 23.20% |
| Profit Margin | 18.64% |
| EBITDA Margin | 25.26% |
| EBIT Margin | 21.46% |
| FCF Margin | 11.83% |
Dividends & Yields
This stock pays an annual dividend of 0.33, which amounts to a dividend yield of 3.08%.
| Dividend Per Share | 0.33 |
| Dividend Yield | 3.08% |
| Dividend Growth (YoY) | -26.85% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 72.58% |
| Buyback Yield | -0.61% |
| Shareholder Yield | 2.47% |
| Earnings Yield | 4.73% |
| FCF Yield | 3.00% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 6 |